Stock Taper
Alamar Biosciences is a commercial-stage proteomics company developing ultra-sensitive, multiplexed protein detection platforms for research and future clinical use, integrating proprietary instruments, consumables, and software.

The ARGO HT is an automated, high-throughput proteomic instrument with fg-level sensitivity, designed for Alamar's NULISA™ assays to enable ultra-sensitive protein biomarker detection for early disease diagnosis and personalized medicine.
| Icon | PRODUCT | Q1-2026 | Q2-2026 |
|---|---|---|---|
![]() | Consumables | $13.96M | $15.48M ▲ |
![]() | Instruments | $7.38M | $7.79M ▲ |
![]() | Service | $4.69M | $6.16M ▲ |
| Map | REGION | Q1-2026 | Q2-2026 |
|---|---|---|---|
![]() | UNITED STATES | $14.9M | $19.66M ▲ |
![]() | EMEA | $3.97M | $6.58M ▲ |
![]() | Asia Pacific | $2.41M | $2.69M ▲ |
![]() | Americas | $1.29M | $503K ▼ |
Overall rating: C